Coffee sales caffeinate J.M. Smucker’s quarterlies. The Folgers maker saw its coffee business surge, helped by higher prices. Profit and revenue came in better than expected. Shares were 6.5 percent higher to $116.29.
Solid sales helped Signet post results that topped estimates. Same-store sales were better than expected. Those results were helped by the firms recent acquisition of the Zale brand. The stock popped 14 percent to $138.82.
Caterpillar announcing plans to cut nearly 500 jobs because of declining revenue. The construction and mining equipment maker said it will consolidate several units of its customer services divisions. Shares were more than two percent higher to $75.66.
Apple unveiling plans for a new product event on September 9th. The tech company is expected to present new iPhones and other devices. Apple has introduced a new iPhone model every year around this time for the past three years, but it’s only dropping vague clues about the event. Shares were nearly three percent higher to $112.92.
The Food and Drug Administration has approved Amgen’s drug for patients with hereditary forms of high cholesterol. Last month, the FDA gave the okay to a similar treatment from Regeneron and Sanofi. These are part of a new class of injectable cholesterol drugs that work differently from statins. Shares were higher in after hours trading. At the end of the regular session, the stock was up one percent to $155.72.